摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-ac-(O-benzyl)tyrosine | 73535-46-3

中文名称
——
中文别名
——
英文名称
N-ac-(O-benzyl)tyrosine
英文别名
(S)-2-Acetamido-3-(4-(benzyloxy)phenyl)propanoic acid;(2S)-2-acetamido-3-(4-phenylmethoxyphenyl)propanoic acid
N-ac-(O-benzyl)tyrosine化学式
CAS
73535-46-3
化学式
C18H19NO4
mdl
——
分子量
313.353
InChiKey
VCXXRMRBSJAWIA-KRWDZBQOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    571.9±50.0 °C(Predicted)
  • 密度:
    1.217±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    23
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    75.6
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-ac-(O-benzyl)tyrosine 在 palladium on activated charcoal 盐酸氢气 、 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下, 以 甲醇乙醚二氯甲烷 为溶剂, 生成 N-acetyl-Tyrosine-Proline-aza-Glycine-amide
    参考文献:
    名称:
    Degradation of Azaglycinamido Residues in Model Tripeptides Derived from Goserelin
    摘要:
    Three model tripeptides, N-acetyl-Tyr-Pro-azaGly-NH2 (NYPaG), Tyr-Pro-azaGly-NH2 (YPaG), and Tyr-Pro-Gly-NH2(YPG), were subjected to a systematic degradation study to get information about the degradation of the azaglycinamido residue. The degradation products were characterized with LC-MS. Main degradation products of NYPaG possess partially or totally eliminated azaglycinamido residues, while YPaG and YPG are exhibit cyclo(Tyr-Pro) formation, a diketopiperazine. The influence of the pH on the degradation rate constant k(obs) was investigated for NYPaG and YPaG in the pH range 0.4-11. An U-shaped profile with an inflexion around pH 9 was found for NYPaG while the degradation rate of YPaG was independent of the pH. NYPaG apparently was subject to proton-, solvent-, and hydroxyl-catalyzed degradation reactions whereas YPaG only underwent solvent-catalyzed reactions. Some influence of acetate and phosphate ions on k(obs) was found fur YPaG. Arrhenius plots of NYPaG and YPaG; were found to be linear. (C) 2000 Wiley-Liss, Inc. and the American Pharmaceutical Association.
    DOI:
    10.1002/(sici)1520-6017(200001)89:1<108::aid-jps11>3.0.co;2-a
  • 作为产物:
    描述:
    2-氨基-3-(4-苯基甲氧基苯基)丙酸甲酯 在 sodium carbonate 、 sodium hydroxide 作用下, 以 甲醇二氯甲烷 为溶剂, 反应 4.0h, 生成 N-ac-(O-benzyl)tyrosine
    参考文献:
    名称:
    Design, synthesis and evaluation of novel metalloproteinase inhibitors based on l-tyrosine scaffold
    摘要:
    A series of novel L-tyrosine derivatives were designed, synthesized and assayed for their inhibitory activities on matrix metalloproteinase 2 (MMP-2) and histone deacetylase 8 (HDAC-8). The results showed that these L-tyrosine derivatives exhibited inhibitory profiles against MMP-2 and HDAC-8. The compounds 6h (IC50 = 0.013 +/- 0.001 mu M) and 6j (IC50 = 0.017 +/- 0.001 mu M) were equal potent MMP-2 inhibitors to the positive control NNGH (IC50 = 0.014 +/- 0.001 mu M). As for HDAC-8 inhibition, some of the hydroxamate compounds, such as 6d (IC50 = 3.6 +/- 0.2 mu M) and 6c (IC50 = 5.8 +/- 0.5 mu M), were equal potent to the positive control SAHA (IC50 = 1.6 +/- 0.1 mu M). Structure-activity relationships were also briefly discussed. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.08.014
点击查看最新优质反应信息

文献信息

  • Production method of O-substituted tyrosine compound
    申请人:Hamada Takayuki
    公开号:US20050283021A1
    公开(公告)日:2005-12-22
    The present invention relates to a method of producing a compound represented by the formula [I] or a salt thereof, which comprises reacting a compound represented by the formula [II] or a salt thereof with a compound represented by the formula [III] or a salt thereof, in the presence of a base, in alcohol, and provides a production method of an O-substituted tyrosine compound, which is superior in productivity, versatility and safety, and economically and industrially useful: wherein each symbol is as defined in the specification.
    本发明涉及一种生产由化学式[I]表示的化合物或其盐的方法,该方法包括在醇中,在碱的存在下,将由化学式[II]表示的化合物或其盐与由化学式[III]表示的化合物或其盐反应,提供了一种生产O-取代酪氨酸化合物的方法,该方法在生产率、多功能性和安全性方面均具有优势,经济上和工业上具有实用价值:其中每个符号如规范中所定义。
  • Polymer-supported Mitsunobu ether formation and its use in combinatorial chemistry
    作者:Viktor Krchňák、Zuzka Flegelová、Aleksandra S. Weichsel、Michal Lebl
    DOI:10.1016/0040-4039(95)01247-f
    日期:1995.8
    primary and secondary alcohols under the conditions of the Mitsunobu reaction (triphenylphosphine and diethyl azodicarboxylate) in tetrahydrofuran. In most cases the reaction provided a nearly quantitative yield of alkyl aryl ethers, as determined after cleaving the product from the resin. To demonstrate that the polymer-supported Mitsunobu reaction is useful for combinatorial library synthesis, we
    芳族羟基酸已经连接到聚合的固体载体上,并且酚羟基已经在Mitsunobu反应(三苯基膦和偶氮二羧酸二乙酯)的条件下在四氢呋喃中与各种伯醇和仲醇反应。在大多数情况下,如从树脂上裂解产物所确定的,该反应提供了几乎定量的烷基芳基醚产率。为了证明聚合物支持的Mitsunobu反应可用于组合文库合成,我们合成了许多模型化合物和一个简单的由4200种不同化合物组成的三步随机化步骤库。
  • <i>p</i>-Nitromandelic Acid as a Highly Acid-Stable Safety-Catch Linker for Solid-Phase Synthesis of Peptide and Depsipeptide Acids
    作者:Albert Isidro-Llobet、Mercedes Alvarez、Klaus Burger、Jan Spengler、Fernando Albericio
    DOI:10.1021/ol063148h
    日期:2007.4.1
    p-Nitromandelic acid as a safety-catch linker for Boc/Bzl-SPPS of base-labile compounds like peptides and depsipeptides is described. This linker permits acidic removal of side-chain protection groups from the resin. For cleavage from the solid support, the p-nitro group was reduced with tin(II) chloride. After washing off the reducing agents, the (depsi)peptide acids with or without the side-chain protection schemes were obtained by microwave irradiation at 50 degrees C with 5% TFA in dioxane.
  • Design of Peptidomimetics That Inhibit the Association of Phosphatidylinositol 3-Kinase with Platelet-Derived Growth Factor-β Receptor and Possess Cellular Activity
    作者:Scott R. Eaton、Wayne L. Cody、Annette M. Doherty、Debra R. Holland、Robert L. Panek、Gina H. Lu、Tawny K. Dahring、David R. Rose
    DOI:10.1021/jm9802766
    日期:1998.10.1
    Phosphorylated tyrosine residues of growth factor receptors that associate with intracellular proteins containing src-homology 2 (SH2) domains are integral components in several signal transduction pathways related to proliferative diseases such as cancer, atherosclerosis, and restenosis. In particular, a phosphorylated pentapeptide [pTyr(751)-Val-Pro-Met(754)-Leu (PTyr = phosphotyrosine)] derived from the primary sequence of platelet-derived growth factor-beta (PDGF-beta) receptor blocks the association of the C-terminal SH2 domain of the p85 subunit of phosphatidylinositol 3-kinase (PI 3-kinase) to PDGF-beta receptor with an IC50 of 0.445 +/- 0.047 mu M. Further evaluation of the structure-activity relationships for pTyr(751)-Val-Pro-Met-Leu resulted in the design of smaller peptidomimetics with enhanced affinity including Ac-pTyr-Val-Ala-N(C6H13)(2) (IC50 = 0.076 +/- 0.010 mu M). In addition, the phosphotyrosine residue was replaced with a difluorophosphonate derivative [4-phosphono(difluoromethyl)phenylalanine (CF(2)Pmp)] which has been shown to be stable to cellular phosphatases. The extracellular administration of either CF(2)Pmp-Val-Pro-Met-Leu or Ac-CF(2)Pmp-Val-Pro-Met-NH2 in a whole cell assay resulted in specific inhibition of the PDGF-stimulated association from the C-terminal SH2 domain of the p85 subunit of PI 3-kinase to the PDGF-beta receptor in a dose-dependent manner. These compounds were also effective in inhibiting GLUT4 translocation, c-fos expression, and cell membrane ruffling in single-cell microinjection assay.
  • Structure-based design of non-peptidic pyridone aldehydes as inhibitors of interleukin-1β converting enzyme
    作者:Julian M.C. Golec、Michael D. Mullican、Mark A. Murcko、Keith P. Wilson、David P. Kay、Stuart D. Jones、Robert Murdoch、Guy W. Bemis、Scott A. Raybuck、Yu-Ping Luong、David J. Livingston
    DOI:10.1016/s0960-894x(97)00394-6
    日期:1997.9
    Pyridone derivatives, especially with 6-aryl substituents, have been shown to be useful P-2-P-3 peptidomimetic scaffolds for the design of potent inhibitors of ICE. (C) 1997 Elsevier Science Ltd.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物